Verastem Inc. (VSTM)

3.41 0 (0%)

IEX Real-Time Price

March 19, 2019 EST.

NASDAQ Global Market : Healthcare

Prev Close 3.41

Price Open 3.37

Volume: 1,399

Avg Volume: 3.2M

Market Cap: 251.88M

P/E Ratio -2.49

52 Wk Range 2.61-10.35



VSTM Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
72.11M
16.5M
3.55
22.88%

2018-09-28
72.03M
14.62M
3.74
20.30%

2018-09-14
72.03M
8.07M
3.29
11.20%

2018-08-31
72.03M
6.59M
2.89
9.15%




VSTM Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-07
Q3 2018
N/A
-0.43 (5)
-0.29
0.14

2018-08-08
Q2 2018
N/A
-0.35 (6)
-0.30
0.05

2018-05-09
Q1 2018
N/A
-0.41 (4)
0.00
0.00

2018-05-03
Q1 2018
N/A
-0.41 (4)
-0.41
0.00

News

PDD, EXPR and ZTO among premarket losers (2019-03-13 09:16 SeekingAlpha)

VivoPower International (NASDAQ: VVPR ) -21% . More news on: VivoPower International PLC, Navios Maritime Holdings Inc., Express, Inc., Stocks on the move, Read more …

 

Verastem, Inc (VSTM) CEO Robert Forrester on Q4 2018 Results - Earnings Call Transcript (2019-03-12 22:52 SeekingAlpha)

Verastem, Inc (VSTM) Q4 2019 Results Earnings Conference Call March 12, 2019 04:30 PM ET Company Participants Robert Forrester - CEO Rob Gagnon - Chief Financial Officer Joseph Lobacki - Chief Commercial Officer Dan Paterson - Chief Operating Officer Conference Call Partic…

 


Statistics

Shares Outstanding: 73.87M

Top 15 Institution Percent: 96.50

Price To Sales: 9.34

Price To Book: 2.01

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -39.89

Return On Equity: -80.70

Profit Margin: N/A

Price History

Beta: 3.06

50-day Moving Avg: 3.28

200-day Moving Avg: 5.79

YTD Change: -5.54

5-day Change: 1.79

1-month Change: 3.33

3-month Change: -7.08

6-month Change: -61.07

1-year Change: 8.25

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Verastem Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.verastem.com

Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib.